Oral/Intramuscular B12 to Treat Cobalamin Deficiency

Status Completed

Clinical Trial Summary

Objective: To determine the effectiveness of oral versus intramuscular Cobalamin (vitamin B12) by restore cobalamin parameter in blood at 8, 26 and 52 weeks in ≥ 65 aged patients with Cobalamin Deficiency.

Design: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (Madrid Region).

Participants: ≥ 65 aged patients with Cobalamin Deficiency. Patients give inform consent. Number of patients: 320 (160 each arm). Assignment: randomized simple (automatic system).

Variables. Main outcome variable: Cobalamin level standardization (yes/no). Secondary outcome variables: Adverse events. Adherence measurement of treatment. Health related quality of life questionnaire (Euroqol-5D). Satisfaction and preferences. Other variables: Gender. Age. Live alone. Vegetarian diet. Alcohols consume. Clinic Variables (symptoms and physical examination) and blood parameters. Drugs consume.

Causes of all losses and withdrawals. Number of patients (age and gender) who declined to participate.

All data (excluding patient identification data) will be record in an electronic database.

Intervention group: oral Optovite® B12 1000 gammas. Control group: idem intramuscular.

Analysis: Descriptive analysis (screening phase). Baseline comparison of the two intervention groups. Effect of cobalamin (main outcome variable). Security. Quality of life. Adherence measurement of treatment.

Clinical Trial Description

Variables. Main outcome variable: Cobalamin level standardization (yes/no). Secondary outcome variables: Adverse events. Adherence measurement of treatment. Health related quality of life questionnaire (Euroqol-5D). Satisfaction and preferences. Other variables: Gender. Age. Live alone. Vegetarian diet. Alcohols consume. Clinic Variables (symptoms and physical examination) and blood parameters. Drugs consume.

Causes of all losses and withdrawals. Number of patients (age and gender) who declined to participate.

All data (excluding patient identification data) will be record in an electronic database.

Intervention group: oral Optovite® B12 1000 gammas. Control group: idem intramuscular.

Analysis: Descriptive analysis (screening phase). Baseline comparison of the two intervention groups. Effect of cobalamin (main outcome variable). Security. Quality of life. Adherence measurement of treatment. ;

Study Design

Related Conditions & MeSH terms

Vitamin B 12 Deficiency

Clinical Trial Details

NCT number	NCT01476007
Study type	Interventional
Source	Gerencia de Atención Primaria, Madrid
Contact
Status	Completed
Phase	N/A
Start date	July 2014
Completion date	November 28, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06100146` - Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls	N/A
Completed	`NCT04083560` - A Comparison of Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment	N/A
Completed	`NCT04632771` - Nutritional Status and Bouillon Use in Northern Ghana
Active, not recruiting	`NCT03853304` - Quadruple Fortified Salt Trial in India	N/A
Completed	`NCT03437824` - Effects of Vitamin B12 Treatment in Singers	Early Phase 1
Active, not recruiting	`NCT05315843` - Cobalamin Supply and Metabolism in Healthy Children From Birth to the Age of 12 Months and in Their Mothers (Cbl_Neo)
Completed	`NCT05614960` - Dried Purple Laver (Nori) as a Food Source of Vitamin B12 in Vegetarians	N/A
Completed	`NCT03444155` - Natural Versus Synthetic Vitamin B Complexes in Human	N/A
Enrolling by invitation	`NCT05389618` - Dietary Challenges in the Population of Nursing Homes' Residents
Completed	`NCT01832129` - Vitamin B12 Acceptance and Biomarker Response Study	Phase 4
Completed	`NCT03365583` - The Impact of Vitamin B12 Deficiency on Infant Gut Microbiota
Active, not recruiting	`NCT03071666` - Vitamin B12 Supplementation During Pregnancy on Cognitive Development	Phase 2/Phase 3
Active, not recruiting	`NCT05426395` - Vitamin B12 Dose Escalation Trial in Pregnancy	Phase 1
Completed	`NCT00710138` - Cobalamin Status in Young Children With Developmental Delay	N/A
Completed	`NCT03284840` - Adults Nutrition as a Protective or Health-risk Factor
Not yet recruiting	`NCT06441721` - Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient
Completed	`NCT03447275` - The Vitamin B Status in Type 2 Diabetes (VITA) Study
Completed	`NCT02860338` - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE	N/A
Active, not recruiting	`NCT05178407` - Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana	N/A
Completed	`NCT05993962` - Effect of Daily Consumption of Vitamin B12 Fortified Yoghurt on Vitamin B12 Status in Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Oral/Intramuscular B12 to Treat Cobalamin Deficiency — OB12

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms